About
Myogenica is developing an induced pluripotent stem cell platform called MyoPAXon for muscle regeneration to treat muscular dystrophies including Duchenne, limb girdle, and Facioscapulohumeral muscular dystrophy.
Explore Myogenica's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.